Democratising access to genetic services

Familial Cancer

Volumn 5, Issue 1, 2006, Pages 117-121

  Williams Jones, Bryn ^a,c   Burgess, Michael M ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Canada; Clinical genetics; Genetic testing; Health care; Hereditary breast cancer; Insurance; Justice; Resource allocation

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; CANADA; CLINICAL GENETICS; COMMERCIAL PHENOMENA; DECISION MAKING; FAMILIAL CANCER; FUNDING; GENETIC SCREENING; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE DISTRIBUTION; HEALTH INSURANCE; HEALTH PRACTITIONER; HEALTH SERVICE; JUSTICE; ONCOGENE; PATENT; PHILOSOPHY; POLICY; PRIORITY JOURNAL; RESOURCE ALLOCATION; TECHNOLOGY;

BREAST NEOPLASMS; BRITISH COLUMBIA; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC SCREENING; GENETIC SERVICES; GOVERNMENT REGULATION; HEALTH CARE COSTS; HEALTH SERVICES ACCESSIBILITY; HUMANS; NATIONAL HEALTH PROGRAMS; PROGRAM DEVELOPMENT; PROGRAM EVALUATION;

EID: 33644917151     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-005-2582-4     Document Type: Article

References (29)

1. SE Gollust SC Hull BS Wilfond 2002 Limitations of direct-to-consumer advertising for clinical genetic testing J Am Med Assoc 288 1762 7
2. Williams-Jones B. Be Ready Against Cancer, Now': Direct-to- Consumer Advertising for Genetic Testing. New Genetics & Society, 2005, In press.
3. Deber R, Narine L, Baranek P, et al. The public-private mix in health care. In: National Forum on Health, (eds). Striking a Balance: Health Care Systems in Canada and Elsewhere. Éditions MultiMondes. Sainte-Foy, QC, 1998: 423-545.
4. CM Flood T Archibald 2001 The illegality of private health care in Canada Can Med Assoc J 164 6 825 30
5. CM Flood 1999 The structure and dynamics of Canada's health care system JG Downie TA Caulfield Canadian Health Law and Policy Butterworths Toronto 5 50
6. Evans RG, Barer ML, Lewis S, Rachlis M, Stoddart GL. Private Highway, One-Way Street: The Deklein and Fall of Canadian Medicare? Centre for Health Sciences and Policy Research; March 2000. Vancouver, B.C., 2000.
7. TA Caulfield MM Burgess B Williams-Jones 2001 Providing genetic testing through the private sector: a view from Canada ISUMA Can J Policy Res 2 3 72 81 (http://www.isuma.net/v02n03/caulfield/caulfield_e.pdf) [accessed: March 30, 2004].
8. N Daniels 1985 Just Health Care Cambridge University Press New York
9. N Daniels 2001 Justice, health, and health care Am J Bioethics 1 2 2 16
10. A Buchanan DW Brock N Daniels D Wikler 2000 From Chance to Choice: Genetics and Justice Cambridge University Press New York
11. N Daniels J Sabin 1998 The ethics of accountability in managed care reform Health Aff 17 5 50 64
12. RF Carter 2001 BRCA1, BRCA2 and breast cancer: a concise clinical review Clin Invest Med 24 3 147 57
13. HA Shih FJ Couch KL Nathanson MA Blackwood TR Rebbeck KA Armstrong 2002 BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic J Clin Oncol 20 4 994 9
14. CI Szabo MC King 1997 Population genetics of BRCA1 and BRCA2 Am J Hum Genet 60 5 1013 20
15. TS Frank AM Deffenbaugh JE Reid 2002 Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals J Clin Oncol 20 6 1480 90
16. K Birmingham 1997 News: Myriad's rationale for wider testing Nat Med 3 709
17. O Smith 1997 News: breast cancer susceptibility tests still valid, companies argue Nat Med 3 709
18. B Williams-Jones 2002 History of a gene patent: tracing the development and application of commercial BRCA testing Health Law J 10 121 44
19. British Columbia Ministry of Health Services, 2003 Federal leadership urged as genetic testing resumes. In: Press Release. Victoria.
20. MM Burgess L d'Agincourt-Canning 2002 Genetic testing for hereditary disease: attending to relational responsibility J Clin Ethics 12 4 361 72
21. MM Burgess MR Hayden 1996 Patients' rights to laboratory data: trinucleotide repeat length in Huntington disease Am J Med Genet 62 6 9
22. SM Cox W [tmp] McKellin 1999 'There's this thing in our family': predictive testing and the construction of risk for Huntington disease Sociol Health Illness 21 5 622 46
23. Krasner J, Marketing of cancer-gene test raises ethical, medical concerns. The Boston Globe March 26, 2003. (http://www. boston.com/dailyglobe2/ 085/business/Marketing_of_cancer_gene_test_raises_ethical_medical_concerns+. shtml) [accessed: April 21, 2003].
24. Associated Press, DNA testing goes DIY. Wired News March 7 2005. (http://www.wired.com/news/medtech/0,1286,66822,00.html) [accessed: March 30 2005].
25. NA Holtzman D Shapiro 1998 The new genetics: genetic testing and public policy Br Med J 316 852 6
26. J Lomas 1997 Reluctant rationers: public input to health care priorities J Health Services Res Policy 2 2 103 11
27. BM Knoppers 2000 Reflections: the challenge of biotechnology and public policy McGill Law J 45 559 66
28. Romanow RJ, 2005 Final Report: Building on Values: The Future of Health Care in Canada. Ottawa, ON: Commission on the Future of Health Care in Canada; 28 November 2002. (http://www.hc-sc.gc.ca/english/care/romanow/hcc0086.html) [accessed: March 30 2005].
29. MM Burgess 2003 Public consultation in ethics: an experiment in representative ethics J Bioeth Inquiry 1 1 4 13